| 1 |
Zhou K, Yang C, Li Y. Multi-omics in colorectal cancer liver metastasis: applications and research advances [J]. Cancer Biol Med, 2025, 22(6): 618-638.
|
| 2 |
Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer [J]. Lancet, 2019, 394(10207): 1467-80.
|
| 3 |
Peng H, Pan Y, Sun Y, et al. Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis [J]. J Immunother Cancer, 2025, 13(6): e011310.
|
| 4 |
Engstrand J, Nilsson H, Strömberg C, et al. Colorectal cancer liver metastases - a population-based study on incidence, management and survival [J]. BMC Cancer, 2018, 18(1): 78.
|
| 5 |
朱德祥, 任黎, 许剑民. 中国结直肠癌肝转移诊断和综合治疗指南(2023版) [J]. 消化肿瘤杂志(电子版), 2023, 15(2): 86-99.
|
| 6 |
Yang F, Mao Y, Huang H, et al. The efficacy and safety of regorafenib/fruquintinib combined with PD-1/PD-L1 for metastatic colorectal cancer: a meta-analysis based on single-arm studies [J]. Front Immunol, 2025, 16: 1579293.
|
| 7 |
姜志超, 张雯, 周爱萍. 晚期结直肠癌三药联合方案化疗的研究进展 [J]. 中国肿瘤临床, 2021, 48(4): 201-205.
|
| 8 |
Ansari D, Rystedt J, Søreide K, et al. The challenge of disappearing colorectal liver metastasis: balancing considerations between tumor biology and clinical consequence for liver surgery [J]. Clin Exp Metastasis, 2025, 42(4): 39.
|
| 9 |
Stavrou GA, Stang A, Raptis DA, et al. Intraoperative (contrast-enhanced) ultrasound has the highest diagnostic accuracy of any imaging modality in resection of colorectal liver metastases [J]. J Gastrointest Surg, 2021, 25(12): 3160-3169.
|
| 10 |
Fergadi MP, Magouliotis DE, Vlychou M, et al. A meta-analysis evaluating contrast-enhanced intraoperative ultrasound (CE-IOUS) in the context of surgery for colorectal liver metastases [J]. Abdom Radiol (NY), 2021, 46(9): 4178-4188.
|
| 11 |
Chang GY, Fetzer DT, Porembka MR. Contrast-enhanced intraoperative ultrasound of the liver [J]. Surg Oncol Clin N Am, 2022, 31(4): 707-719.
|
| 12 |
Li H, Shi M, Long X, et al. Contrast-enhanced intraoperative ultrasound improved hepatic recurrence-free survival in initially unresectable colorectal cancer liver metastases [J]. Dig Liver Dis, 2025, 57(2): 467-476.
|
| 13 |
Liu W, Zhang ZY, Yin SS, et al. Contrast-enhanced intraoperative ultrasound improved sensitivity and positive predictive value in colorectal liver metastasis: a systematic review and meta-analysis [J]. Ann Surg Oncol, 2021, 28(7): 3763-3773.
|
| 14 |
Chen JY, Dai HY, Li CY, et al. Improved sensitivity and positive predictive value of contrast-enhanced intraoperative ultrasound in colorectal cancer liver metastasis: a systematic review and meta-analysis [J]. J Gastrointest Oncol, 2022, 13(1): 221-230.
|
| 15 |
Takayama M, Ito K, Karako K, et al. An artificial intelligence-based recognition model of colorectal liver metastases in intraoperative ultrasonography with improved accuracy through algorithm integration [J]. J Hepatobiliary Pancreat Sci, 2025, 32(1): 58-68.
|
| 16 |
Kataoka K, Mauer M, Shiozawa M, et al. Diagnostic accuracy of imaging in assessing nonviability of disappearing colorectal liver metastasis [J]. JAMA Surg, 2025, 160(11): 1212-1220.
|
| 17 |
Kuhlmann K, van Hilst J, Fisher S, et al. Management of disappearing colorectal liver metastases [J]. Eur J Surg Oncol, 2016, 42(12): 1798-1805.
|
| 18 |
Qin S, Chen Y, Wang Y, et al. Contrast-enhanced ultrasound with microbubbles containing sulfur hexafluoride and perfluorobutane with Kupffer phase for the detection of colorectal liver metastases [J]. Eur Radiol, 2024, 34(1): 622-631.
|
| 19 |
Sun L, Yin S, Xing B, et al. Contrast-enhanced ultrasound with sonovue and sonazoid for the diagnosis of colorectal liver metastasis after chemotherapy [J]. J Ultrasound Med, 2023, 42(2): 355-362.
|
| 20 |
Chami L, Lassau N, Malka D, et al. Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings [J]. AJR Am J Roentgenol, 2008, 190(3): 683-690.
|
| 21 |
Arita J, Ono Y, Takahashi M, et al. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy [J]. Ann Surg Oncol, 2014, 21 Suppl 3: S390-S397.
|
| 22 |
Muaddi H, Silva S, Choi WJ, et al. When is a ghost really gone? A systematic review and meta-analysis of the accuracy of imaging modalities to predict complete pathological response of colorectal cancer liver metastases after chemotherapy [J]. Ann Surg Oncol, 2021, 28(11): 6805-6813.
|
| 23 |
Oba A, Mise Y, Ito H, et al. Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography [J]. HPB (Oxford), 2018, 20(8): 708-714.
|
| 24 |
Kim SS, Song KD, Kim YK, et al. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required? [J]. Eur Radiol, 2017, 27(7): 3088-3096.
|
| 25 |
Barimani D, Kauppila JH, Sturesson C, et al. Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review [J]. World J Surg Oncol, 2020, 18(1): 264.
|
| 26 |
Tani K, Shindoh J, Akamatsu N, et al. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors [J]. J Surg Oncol, 2018, 117(2): 191-197.
|
| 27 |
Boraschi P, Moretto R, Donati F, et al. Exploring the outcome of disappearance or small remnants of colorectal liver metastases during first-line chemotherapy on hepatobiliary contrast-enhanced and diffusion-weighted MR imaging [J]. Cancers (Basel), 2023, 15(8): 2200.
|
| 28 |
Bitterer F, Bauer A, Glehr G, et al. Intraoperative contrast-enhanced ultrasound has an outcome-relevant impact on surgery of primary and metastatic liver lesions [J]. Ultraschall Med, 2025, 46(1): 49-56.
|
| 29 |
Desolneux G, Isambert M, Mathoulin-Pelissier S, et al. Contrast-enhanced intra-operative ultrasound as a clinical decision making tool during surgery for colorectal liver metastases: the ULIIS study [J]. Eur J Surg Oncol, 2019, 45(7): 1212-1218.
|
| 30 |
Hiroyoshi J, Yamashita S, Tanaka M, et al. Contrast-enhanced intraoperative ultrasound in the resection of colorectal liver metastases with intrabiliary growth [J]. Clin J Gastroenterol, 2018, 11(5): 348-353.
|
| 31 |
周宏岩, 于韬. 超声新技术在结直肠癌肝转移诊疗中的应用进展 [J]. 现代肿瘤医学, 2019, 27(10): 1820-1823.
|
| 32 |
陈丽梅, 刘广健, 邓艳红, 等. 结直肠癌肝转移瘤热消融治疗国际专家共识分享 [J]. 中国介入影像与治疗学, 2018, 15(6): 323-326.
|
| 33 |
姚智航, 张凯, 骆银根, 等. 热消融与手术切除治疗异时性结直肠癌肝转移的临床疗效比较 [J]. 四川大学学报(医学版), 2022, 53(3): 481-487.
|
| 34 |
Ruers T, Van Coevorden F, Punt CJ, et al. Local treatment of unresectable colorectal liver metastases: results of a randomized phase Ⅱ trial [J]. J Natl Cancer Inst, 2017, 109(9): djx015.
|
| 35 |
葛云鹏, 吴明晓, 李晨, 等. 超声造影辅助射频消融治疗结直肠癌肝转移术后短期复发及相关危险因素的单中心回顾性研究 [J]. 中华转移性肿瘤杂志, 2024, 7(4): 320-325.
|
| 36 |
Qin S, Zhou J, Cui R, et al. Percutaneous ablation of colorectal liver metastases: a comparison between the outcomes of grayscale US guidance and Sonazoid CEUS Kupffer phase guidance using propensity score matching [J]. Int J Hyperthermia, 2023, 40(1): 2260573.
|
| 37 |
Li L, Zhang L, Han X, et al. The Short-term efficacy of contrast-enhanced ultrasound (CEUS) and Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) fusion imaging-guided radiofrequency ablation (RFA) for colorectal liver metastasis (CRLM) [J]. Curr Med Imaging, 2023. Online ahead of print.
|
| 38 |
Zhao QX, He XL, Wang K, et al. Deep learning model based on contrast-enhanced ultrasound for predicting early recurrence after thermal ablation of colorectal cancer liver metastasis [J]. Eur Radiol, 2023, 33(3): 1895-1905.
|
| 39 |
Lin J, Liu H, Liang S, et al. The relationship between rim-like enhancement on pre-ablation contrast-enhanced ultrasound of colorectal liver metastasis and early intrahepatic progression after thermal ablation: a preliminary study [J]. Ultrasound Med Biol, 2025, 51(2): 358-363.
|
| 40 |
Li C, Liu Y, Xu J, et al. Contrast-enhanced intraoperative ultrasonography with Kupffer phase may change treatment strategy of metastatic liver tumors-a single-centre prospective study [J]. Ther Clin Risk Manag, 2021, 17: 789-796.
|
| 41 |
Laimer G, Verdonschot KHM, Kopf L, et al. Multicenter and inter-software evaluation of ablative margins after thermal ablation of colorectal liver metastases [J]. Eur Radiol, 2025, 35(2): 1046-1056.
|
| 42 |
Paolucci I, Albuquerque Marques Silva J, Lin YM, et al. Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation [J]. Br J Surg, 2024, 111(9): znae165.
|
| 43 |
Paolucci I, Albuquerque Marques Silva J, Lin YM, et al. Quantitative ablation confirmation methods in percutaneous thermal ablation of malignant liver tumors: technical insights, clinical evidence, and future outlook [J]. Radiol Imaging Cancer, 2025, 7(3): e240293.
|
| 44 |
Bo XW, Xu HX, Guo LH, et al. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers [J]. Br J Radiol, 2017, 90(1078): 20170063.
|
| 45 |
Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative [J]. Radiology, 2021, 301(3): 533-540.
|
| 46 |
Lin YM, Paolucci I, Albuquerque Marques Silva J, et al. Ablative margin quantification using deformable versus rigid image registration in colorectal liver metastasis thermal ablation: a retrospective single-center study [J]. Eur Radiol, 2024, 34(9): 5541-5550.
|
| 47 |
梁婧玲, 李惠玲, 高希法, 等. 超声造影和CT检查在结直肠癌肝转移行肝转移灶切除术前评估的价值 [J]. 肝脏, 2018, 23(11): 1015-1018.
|
| 48 |
Liu L, Cui WC, Sun Y, et al. Classification of neoadjuvant therapy response in patients with colorectal liver metastases using contrast-enhanced ultrasound-with histological pathology as the gold standard [J]. Ultrasound Med Biol, 2025, 51(1): 102-111.
|
| 49 |
Zhang XL, Wang HT, Tang Y, et al. Colorectal liver metastases: correlations of contrast-enhanced ultrasound features with tumor clinicopathological factors and clinical outcomes following conversion therapy [J]. Clin Hemorheol Microcirc, 2024, 86(3): 339-356.
|
| 50 |
徐丽荣, 孙月, 王锦, 等. 超声造影定量参数在结直肠癌肝转移靶向治疗疗效评价中的作用研究 [J]. 解放军预防医学杂志, 2019, 37(11): 136-137, 139.
|
| 51 |
Zhou BY, Liu H, Pu YY, et al. Quantitative analysis of pre-treatment dynamic contrast-enhanced ultrasound for assessing the response of colorectal liver metastases to chemotherapy plus targeted therapy: a dual-institutional study [J]. Abdom Radiol (NY), 2024, 49(2): 414-424.
|
| 52 |
王雪伟, 黄晓云, 庞长绪, 等. 超声造影定量分析在结直肠癌肝转移化疗早期疗效评价中的应用价值 [J]. 中国肛肠病杂志, 2022, 42(2): 28-30.
|
| 53 |
Mogensen MB, Hansen ML, Henriksen BM, et al. Dynamic contrast-enhanced ultrasound of colorectal liver metastases as an imaging modality for early response prediction to chemotherapy [J]. Diagnostics (Basel), 2017, 7(2): 35.
|
| 54 |
刘代江, 万晓强, 刘瑶, 等. 超声造影早期评估结直肠癌肝转移患者抗血管生成靶向治疗效果的研究 [J]. 临床超声医学杂志, 2023, 25(3): 208-212.
|
| 55 |
杨琛, 朱利明, 彭婵娟, 等. 超声造影定量分析在晚期结直肠癌患者抗血管治疗早期疗效评估中的作用 [J]. 中华超声影像学杂志, 2016, 25(6): 510-515.
|
| 56 |
Luo Y, Lin D, Tian H, et al. Classification and clinical application of ultrasound contrast agents [J]. Ultrason Imaging, 2025, 47(3-4): 153-167.
|
| 57 |
刘丽, 王红, 杨薇. 超声造影在肝脏恶性肿瘤系统治疗中的应用现状及进展 [J]. 中华超声影像学杂志, 2023, 35(5): 420-425.
|
| 58 |
Shang P, Gao R, Zhu Y, et al. Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433] [J]. Acta Pharm Sin B, 2024, 14(6): 2790.
|
| 59 |
Hackl C, Schacherer D, Anders M, et al. Improved detection of preclinical colorectal liver metastases by high resolution ultrasound including molecular ultrasound imaging using the targeted contrast agent BR55 [J]. Ultraschall Med, 2016, 37(3): 290-296.
|
| 60 |
Helbert A, Von Wronski M, Colevret D, et al. Ultrasound molecular imaging with BR55, a predictive tool of antiangiogenic treatment efficacy in a chemo-induced mammary tumor model [J]. Invest Radiol, 2020, 55(10): 657-665.
|
| 61 |
洪运虎, 王桂林, 劳海燕, 等. 常规及VEGFR2靶向超声造影在结直肠癌肝转移靶向治疗疗效评价中作用研究[J]. 中国超声医学杂志, 2017, 33(9): 836-839.
|
| 62 |
Wegierak D, Nittayacharn P, Cooley MB, et al. Nanobubble contrast enhanced ultrasound imaging: a review [J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2024, 16(6): e2007.
|
| 63 |
赵萍, 马晓菊, 杨恒丽, 等. 携ApoPep-1纳米微泡靶向成像评价活体内肿瘤凋亡的实验研究 [J]. 中国医学影像学杂志, 2020, 28(12): 901-906.
|
| 64 |
Zhang G, Ye HR, Sun Y, et al. Ultrasound molecular imaging and its applications in cancer diagnosis and therapy [J]. ACS Sens, 2022, 7(10): 2857-2864.
|